“…Over 1.5 million prescriptions are written each year in Australia for topical potent corticosteroids such as betamethasone, dexamethasone, and triamcinolone, some of which are used by pregnant women. Unless they also contain aminoglycosides, the pregnancy category for these preparations is “A”: “drugs which have been taken by a large number of pregnant women and women of child‐bearing age without any proven increase in the frequency of malformations or other direct or indirect harmful effects on the fetus having been observed.” Systemic absorption depends on the type and dosage of preparation used and the nature and extent of the underlying skin condition, but it can be significant, especially with repeated applications [Mizuchi et al, 1976; Schaefer et al, 1977; Wester et al, 1980; Turpeinen, 1991; Barnetson and White, 1992; Melendres et al, 1992].…”